Loading...
UK Trademark — IPO
FORTY SEVEN
Application UK00801367188 · Registered
Quick Facts
| Application Number | UK00801367188 |
| Status | Registered |
| Owner | Forty Seven, Inc |
| Filed | 2017-08-15 |
| Registered | 2018-03-02 |
| Renewal Due | 2027-08-15 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. FORTY SEVEN is currently a registered UK trademark, with renewal due on 2027-08-15. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Pharmaceutical preparation for the treatment of cancer.
Timeline
- Filed: 2017-08-15
- Registered: 2018-03-02
- Renewal due: 2027-08-15
About This Trademark
'FORTY SEVEN' is a registered trademark on the UK IPO register, owned by Forty Seven, Inc. The application (UK00801367188) was filed on 15 August 2017 and registered on 2 March 2018. The registration is set to expire on 15 August 2027.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by John W. Crittenden Cooley LLP.
Frequently Asked Questions
Who owns UK trademark UK00801367188 ('FORTY SEVEN')?
UK trademark UK00801367188 for the mark 'FORTY SEVEN' in Class 5 is recorded on the UK IPO register as owned by Forty Seven, Inc. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00801367188 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00801367188 for the mark 'FORTY SEVEN' as registered.
Which goods or services does UK trademark UK00801367188 cover?
UK trademark UK00801367188 for the mark 'FORTY SEVEN' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical preparation for the treatment of cancer.
When was UK trademark UK00801367188 filed?
UK trademark UK00801367188 for the mark 'FORTY SEVEN' was filed at the UK IPO on 15 August 2017 and registered on 2 March 2018.
When does UK trademark UK00801367188 need to be renewed?
UK trademark UK00801367188 for the mark 'FORTY SEVEN' is currently recorded as valid until 15 August 2027, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00801367188?
John W. Crittenden Cooley LLP is listed as the attorney / representative of record for UK trademark UK00801367188 for the mark 'FORTY SEVEN' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "FORTY SEVEN" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| FORTY SEVENSame applicant | 87357605 | 606 | 2017-03-03 |
| FORTY SEVENSame applicant | 86750461 | 710 | 2015-09-08 |
| FORTY SEVEN | 85889148 | 702 | 2013-03-28 |
| FORTY SEVEN | 85203798 | 606 | 2010-12-22 |
| FORTY SEVEN | 85977645 | 800 | 2010-12-22 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.